Increased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma

por Gao, Jing, Zou, Zhengzhi, Gao, Jing, Zhang, Haifang, Lin, Zhicai, Zhang, Yaya, Luo, Xianyang, Liu, Changhua, Xie, Jingdun, Cai, Chengfu
Publicado no Int J Clin Exp Pathol (2015)

A Suppressor of Cytokine Signaling 1 Antagonist Enhances Antigen-Presenting Capacity and Tumor Cell Antigen-Specific Cytotoxic T Lymphocyte Responses by Human Monocyte-Derived Dend...

por Wang, Yongjun, Wang, Shengyu, Ding, Yuan, Ye, Yanhua, Xu, Yingyi, He, Huixiang, Li, Qiaozhen, Mi, Yanjun, Guo, Chunhua, Lin, Zhicai, Liu, Tao, Zhang, Yaya, Chen, Yuqiang, Yan, Jianghua
Publicado em 2013

PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report

por Li, Chenggong, Sun, Yan, Wang, Jing, Tang, Lu, Jiang, Huiwen, Guo, Tao, Liu, Lin, Wu, Yaohui, Ai, Lisha, Xia, Linghui, Wu, Jianjun, Lin, Zhicai, Qian, Qijun, Hu, Yu, Mei, Heng
Publicado no Front Immunol (2021)

αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib

por Fang, Juemin, Ding, Na, Guo, Xianling, Sun, Yan, Zhang, Zhiwei, Xie, Bailu, Li, Zhong, Wang, Hui, Mao, Wei, Lin, Zhicai, Qin, Fei, Yuan, Min, Chu, Wenqi, Qin, Huanlong, Qian, Qijun, Xu, Qing
Publicado no J Immunother Cancer (2021)